Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BRIEF-AstraZeneca says no change in dividend, M&A strategy under new CFO

By: Reuters: Company News
Oct 31 (Reuters) - AstraZeneca CEO Pascal Soriot, speaking to reporters: * CEO says new CFO Dunoyer brings blend of strategic thinking and financial
Related Stocks:
Astrazeneca Plc ADR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.